Delivery Order SPE2DB20D2014-SPE2DB25FB79Q
Award Date
4/30/25
Potential Completion Date
5/1/25
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Refresh Plus 0.5% eye drops. The contract has a ceiling value of $1,206.20 and an ultimate completion date of August 1, 2024. It is a firm-fixed-price contract, with no set-aside designation. Amerisourcebergen, through its extensive supply chain and distribution network, will provide these medical supplies to support military treatment...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Refresh Plus 0.5% eye drops, a pharmaceutical product, with a ceiling value of $1,504.56 and a performance period ending on June 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Refresh Plus 0.5% eye drops. The contract has a firm fixed price, a ceiling value of $3,763.95, and a performance period through June 30, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Refresh Plus 0.5% eye drops in 70-count units, with a firm fixed price of $2,945.98 and an ultimate completion date of June 13, 2025. The contract is not set aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,975.52, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Refresh Plus 0.5% eye drops, a pharmaceutical product. The award is a firm fixed price delivery order contract with a performance period through March 20, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,420.55, is for the delivery of "REFRESH PLUS 0.5% EYE DROPS UD 70S" and has a completion date of June 26, 2024. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which is valued at $999,999,999 and runs through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Refresh Plus 0.5% eye drops, a prescription medication. The contract is a firm fixed-price, non-set-aside contract with a ceiling value of $2,477.85 and a period of performance through June 18, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,929.59, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Refresh Plus 0.5% eye drops in 30-count packages, with a completion date of January 15, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,658.52, is for the delivery of "REFRESH PLUS 0.5% EYE DROPS UD 70S" medical supplies. It is a firm fixed-price delivery order contract with a completion date of May 29, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of "Refresh Plus 0.5% Eye Drops 30s", a medical product, with a firm fixed price ceiling value of $2,861.28 and a period of performance through June 11, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a...